4.6 Article

Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins

Journal

TOXICOLOGY AND APPLIED PHARMACOLOGY
Volume 259, Issue 2, Pages 263-268

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.taap.2012.01.008

Keywords

Skeletal muscle; Sta tins; Calcium homeostasis; Mitochondria; Muscle pain

Funding

  1. agence francaise de securite sanitaire des produits de sante (AFSSAPS)
  2. institut national de la sante et de la recherche medicale (INSERM)
  3. association francaise contre les myopathies (AFM)
  4. fondation pour la recherche medicale (FRM)

Ask authors/readers for more resources

The most common and problematic side effect of statins is myopathy. To date, the patho-physiological mechanisms of statin myotoxicity are still not clearly understood. In previous studies, we showed that acute application in vitro of simvastatin caused impairment of mitochondrial function and dysfunction of calcium homeostasis in human and rat healthy muscle samples. We thus evaluated in the present study, mitochondrial function and calcium signaling in muscles of patients treated with statins, who present or not muscle symptoms, by oxygraphy and recording of calcium sparks, respectively. Patients treated with statins showed impairment of mitochondrial respiration that involved mainly the complex I of the respiratory chain and altered frequency and amplitude of calcium sparks. The muscle problems observed in statin-treated patients appear thus to be related to impairment of mitochondrial function and muscle calcium homeostasis. confirming the results we previously reported in vitro. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available